Compare Khandwala Sec. with Similar Stocks
Stock DNA
Capital Markets
INR 31 Cr (Micro Cap)
NA (Loss Making)
23
0.00%
0.10
-6.52%
1.13
Total Returns (Price + Dividend) 
Khandwala Sec. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Khandwala Securities Q3 FY26: Losses Deepen as Brokerage Firm Struggles with Revenue Collapse
Khandwala Securities Ltd., the Mumbai-based institutional dealing and investment banking firm, reported a concerning third quarter for FY2026, posting a net loss of ₹0.49 crores compared to a profit of ₹0.54 crores in the year-ago quarter. The sharp deterioration represents a 190.74% year-on-year decline, as the company grapples with a severe revenue contraction that has pushed it into operating losses. The micro-cap brokerage firm's market capitalisation stands at ₹31.00 crores, with shares trading at ₹19.20 following a 9.35% decline on February 12, 2026.
Read full news article
Khandwala Securities Ltd is Rated Strong Sell
Khandwala Securities Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Khandwala Securities Ltd Stock Hits 52-Week Low at Rs.18
Khandwala Securities Ltd, a player in the Capital Markets sector, has touched a new 52-week low of Rs.18 today, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance.
Read full news article Announcements 
Board Meeting Intimation for Considering And Approving Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025
04-Feb-2026 | Source : BSEKhandwala Securities Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve (a) Un-audited Financial Results (Standalone and Consolidated) for the Quarter and Nine months ended December 31 2025 (b) any other matter with the permission of the chair.
Closure of Trading Window
31-Dec-2025 | Source : BSEPlease find enclosed intimation of closure of trading window from January 1 2026 for all the Directors Officers Employees Promoter and Promoters Group designated persons and any immediate relatives of them.
Submission Of Revised Unaudited Financial Results And Outcome Of Board Meeting Held On Monday 10Th November 2025
30-Dec-2025 | Source : BSEWith reference to our earlier submission dated November 10 2025; Please find enclosed revised unaudited financial results for the quarter and half year ended September 30 2025 and outcome of board meeting dated November 10 2025.
Corporate Actions 
(12 Feb 2026)
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Jayantilal Khandwala & Sons Pvt. Ltd. (11.36%)
Poonam Balram Bharwani (5.08%)
41.5%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -68.82% vs 198.25% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -304.17% vs 140.68% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -19.79% vs 60.34% in Sep 2024
Growth in half year ended Sep 2025 is -147.89% vs 184.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -33.01% vs 46.92% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -166.40% vs 140.38% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 11.97% vs 36.10% in Mar 2024
YoY Growth in year ended Mar 2025 is -570.59% vs -61.36% in Mar 2024






